[Federal Register Volume 88, Number 67 (Friday, April 7, 2023)]
[Notices]
[Pages 20892-20893]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07333]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Heritable Disorders in 
Newborns and Children

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Committee on Heritable Disorders in 
Newborns and Children (ACHDNC or Committee) scheduled a public meeting. 
Information about ACHDNC and the agenda for this meeting can be found 
on the ACHDNC website at https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html.

DATES: Thursday, May 4, 2023, from 9:30 a.m. to 3:00 p.m. Eastern Time 
and Friday, May 5, 2023, from 9:30 a.m. to 2:00 p.m. Eastern Time.

ADDRESSES: This meeting will be held in person with an option to join 
virtually. While this meeting is open to the public, advance 
registration is required. Please visit the ACHDNC website for 
information on registration: https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html by the deadline of 12:00 p.m. ET on May 
3, 2023. Instructions on how to access the meeting via webcast will be 
provided upon registration.
    If you are a non-U.S. citizen who would like to attend the May 
meeting in-person, please contact [email protected] by April 12, 2023.

FOR FURTHER INFORMATION CONTACT: Alaina Harris, Maternal and Child 
Health Bureau, HRSA, 5600 Fishers Lane, Room 18W66, Rockville, Maryland 
20857; 301-443-0721; or [email protected].

SUPPLEMENTARY INFORMATION: ACHDNC provides advice and recommendations 
to the Secretary of Health and Human Services (Secretary) on the 
development of newborn screening activities, technologies, policies, 
guidelines, and programs for effectively reducing morbidity and 
mortality in newborns and children having, or at risk for, heritable 
disorders. ACHDNC reviews and reports regularly on newborn and 
childhood screening practices, recommends improvements in the national 
newborn and childhood screening programs, and fulfills requirements 
stated in the authorizing legislation. In addition, ACHDNC's 
recommendations regarding inclusion of additional conditions for 
screening on the Recommended Uniform Screening Panel, following 
adoption by the Secretary, are evidence-informed preventive health 
services provided for in the comprehensive guidelines supported by HRSA 
pursuant to section 2713 of the Public Health Service Act (42 U.S.C. 
300gg-13). Under this provision, non-grandfathered group health plans 
and health insurance issuers offering non-grandfathered group or 
individual health insurance are required to provide insurance coverage 
without cost-sharing (a co-payment, co-insurance, or deductible) for 
preventive services for plan years (i.e., policy years) beginning on or 
after the date that is 1 year from the Secretary's adoption of the 
condition for screening.
    During the May 4-5, 2023, meeting, ACHDNC will hear from experts in 
the fields of public health, medicine, heritable disorders, rare 
disorders, and newborn screening. Agenda items may include the 
following topics:
    (1) ACHDNC committee processes including prioritization and 
capacity of reviewing initial nominations;

[[Page 20893]]

    (2) Criteria for pilot studies related to newborn screening;
    (3) Center for Disease Control and Prevention's Enhancing Data 
Driven Disease Detection in Newborns (ED3N) Project; and
    (4) ACHDNC Decision Matrix.
    Agenda items are subject to change as priorities dictate. However, 
no votes will be held at this meeting to recommend including additional 
conditions for screening to the Recommended Uniform Screening Panel. 
Information about ACHDNC, including a roster of members and past 
meeting summaries, is also available on ACHDNC's website.
    Members of the public also will have the opportunity to provide 
comments on any or all of the above agenda items. Public participants 
may request to provide general oral comments and may submit written 
statements in advance of the scheduled meeting. Oral comments will be 
honored in the order they are requested and may be limited as time 
allows. Members of the public registered to provide oral public 
comments on all other newborn screening related topics are tentatively 
scheduled to provide their statements on Friday, May 5, 2023. Requests 
to provide a written statement or make oral comments to the ACHDNC must 
be submitted via the registration website by 12:00 p.m. ET on 
Wednesday, April 19, 2023. Written comments will be shared with the 
Committee, so that they have an opportunity to consider them prior to 
the meeting.
    Individuals who need special assistance or another reasonable 
accommodation should notify Alaina Harris at the address and phone 
number listed above at least 10 business days prior to the meeting.
    Since this meeting occurs in a federal government building, 
attendees must go through a security check to enter the building. Non-
U.S. citizen attendees must notify HRSA of their planned attendance at 
least 15 business days prior to the meeting in order to facilitate 
their entry into the building. All attendees are required to present 
government-issued identification prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-07333 Filed 4-6-23; 8:45 am]
BILLING CODE 4165-15-P